Combination of dabrafenib (DAB) and lapatinib (LAP) for the treatment of BRAF-mutant thyroid cancer Meeting Abstract
| Authors: | Sherman, E. J.; Ho, A. L.; Fagin, J. A.; Haque, S.; Robinson, C.; Ghossein, R. A.; Chen, H. X.; Pfister, D. G. |
| Abstract Title: | Combination of dabrafenib (DAB) and lapatinib (LAP) for the treatment of BRAF-mutant thyroid cancer |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 344s |
| Language: | English |
| ACCESSION: | WOS:000442916002377 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.6087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6087 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
